Back to results
TerminatedPhase 1Phase 2

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

NCT01560585

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Parkway Medical Building

Beachwood, Ohio, United States

View on ClinicalTrials.gov
Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease — TrialFind